Cash from Investing (Quarterly) Chart

Historical Cash from Investing (Quarterly) Data

View and export this data back to 2007. Start Trial.
Date Value
July 31, 2026 -0.0559M
April 30, 2026 0.1106M
January 31, 2026 10.25M
October 31, 2025 -0.0491M
July 31, 2025 -0.4323M
April 30, 2025 -0.2522M
January 31, 2025 -0.0697M
October 31, 2024 -0.0481M
July 31, 2024 -0.192M
April 30, 2024 -0.8178M
January 31, 2024 0.0409M
October 31, 2023 -0.2274M
July 31, 2023 -0.1476M
April 30, 2023 -0.3223M
January 31, 2023 -0.1548M
October 31, 2022 -0.9056M
July 31, 2022 -0.0692M
April 30, 2022 -3.230M
January 31, 2022 -0.5215M
October 31, 2021 -0.0822M
July 31, 2021 -0.2766M
April 30, 2021 -0.6785M
January 31, 2021 -0.3159M
October 31, 2020 -0.5543M
July 31, 2020 -0.4025M
Date Value
April 30, 2020 0.0248M
January 31, 2020 -0.976M
October 31, 2019 -0.1365M
July 31, 2019 -0.0614M
April 30, 2019 -0.4563M
January 31, 2019 -0.8822M
October 31, 2018 -0.296M
July 31, 2018 -0.0185M
April 30, 2018 -2.823M
January 31, 2018 -0.0558M
October 31, 2017 -2.602M
July 31, 2017 -0.1405M
April 30, 2017 0.0558M
January 31, 2017
June 30, 2016
March 31, 2016
December 31, 2015 0.0006M
September 30, 2015 0.00
June 30, 2015 0.00
March 31, 2015 0.00
December 31, 2014 -0.0428M
September 30, 2014 0.0001M
June 30, 2014 0.0422M
March 31, 2014 0.00
December 31, 2013 0.0885M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
Repligen Corp. -2.089M
Bio-Techne Corp. -7.057M
BioLife Solutions, Inc. -1.579M
Maravai Lifesciences Holdings, Inc. -0.37M
MaxCyte, Inc. 6.566M